Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18
Closed -$2.4K 51
2023
Q1
$2.4K Buy
18
+4
+29% +$470 ﹤0.01% 819
2022
Q4
$1.11K Sell
14
-1
-7% -$70 ﹤0.01% 1134
2022
Q3
$1K Buy
15
+6
+67% +$388 ﹤0.01% 975
2022
Q2
$0 Buy
9
+6
+200% +$348 ﹤0.01% 1426
2022
Q1
$0 Buy
+3
New +$205 ﹤0.01% 1052

Other funds holding ACLS

Schubert & Co's ACLS Position: Q2 2023 in Review

Schubert & Co sold out of Axcelis (ACLS) in Q2 2023, closing a stake of 18 shares — an estimated $2.4K sold.

Schubert & Co first reported a position in ACLS in Q1 2022 and held it in 5 quarters. The position peaked at $2.4K in Q1 2023. 405 funds tracked by Wall St. Rank hold ACLS as of Q2 2023.

  • Schubert & Co reported no remaining Axcelis position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 18 Axcelis shares in Q2 2023, an estimated $2.4K.
  • Schubert & Co first reported a position in Axcelis in Q1 2022 and held it in 5 quarters.
  • Schubert & Co's Axcelis position peaked at $2.4K in Q1 2023.
  • 405 funds tracked by Wall St. Rank held Axcelis as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.